Hybrid scaffold-balloon vs standard stent for long blockages
Part of Heart & circulation clinical trials.
This trial tests a new way to treat long, narrow blockages in heart arteries. Instead of using a standard permanent metal stent, doctors will combine a temporary scaffold with a special balloon that releases medication. The goal is to see if this approach works as well as or better than the usual metal stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a long (over 40 mm) narrowed area in one or more of your heart arteries.
- You must be stable enough for a heart procedure (not in severe shock).
- You cannot have had a stent placed in that same heart artery in the last 12 months.
- You must be able to take two blood thinners (aspirin plus clopidogrel, prasugrel, or ticagrelor) for at least 6 months.
- You cannot have a known allergy to the components of the trial devices or blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a drug-coated balloon with a scaffold is better than using a scaffold alone for people with narrowed or blocked heart arteries. It looks at which method helps the artery stay open longer.
This trial compares two types of small mesh tubes (scaffolds and stents) to open blocked heart arteries. It is for people having a specific kind of heart attack or unstable angina who need a stent.
This trial tests if using advanced imaging (like OCT or IVUS) to guide placement of a newer type of stent (bioresorbable scaffold) can reduce future stent problems. It is for people with stable coronary artery disease who need a stent in a main heart artery.
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.